Beth Seidenberg Biography

Beth joined Kleiner Perkins Caufield & Byers in May 2005 to work in life sciences. For the past 20 years she has focused her career on introducing new innovative treatments for AIDS arthritis asthma cancer psoriasis cardiovascular metabolic neurological and renal disorders.
Seidenberg has introduced 10 innovative products to market and achieved over 40 regulatory approvals including new indications and formulations worldwide. These products have been successfully commercialized and provided benefits to millions of patients with grievous illnesses and they have generated several billion dollars of revenue.
Prior to joining KPCB Beth was Senior Vice President Global Development and Chief Medical Officer at Amgen Inc. the world's largest biotechnology company. During Beth's three years there her responsibilities included all stages of clinical research regulatory affairs safety health economics/reimbursement and medical affairs. During her tenure five innovative products were approved for commercial use. Prior to joining Amgen Beth was a senior executive in research and development at Bristol-Myers Squibb Company and Merck & Co. Inc.

As a renowned expert and highly sought-after speaker, Beth Seidenberg's expertise is in high demand. To book Beth Seidenberg for your next event, conference, or workshop, please contact our speaker booking agency. Our experienced team will work closely with you to understand your specific needs and help secure Beth Seidenberg's participation. With our professional guidance and seamless booking process, you can ensure a memorable and impactful experience for your audience. Don't miss the opportunity to engage your audience with Beth Seidenberg's compelling insights and inspire positive change within your organization. Fill out the booking request form to take the first step in securing Beth Seidenberg for your next speaking engagement.